Aggressive lipid-lowering therapy before and after revascularization in patients with stable coronary artery disease
https://doi.org/10.21518/2079-701X-2013-4-2-55-61
Abstract
The review presents data on the effectiveness of lipid profile correction with maximum doses of statins, primarily atorvastatin, and lipoprotein apheresis. The results of large-scale studies and meta-analyses evaluating the use of statins before and after coronary artery bypass surgery and stenting to reduce the risk of both early and late cardiovascular complications, and the need for revascularization of the myocardium, were analyzed. Lipid apheresis in patients with coronary artery disease who underwent coronary stenting or bypass surgery, and with hypercholesterolemia refractory to lipotropic therapy, is associated with reduced risk of in-stent restenosis, as well as destruction of bypass. Therefore, this method can be recommended to be used in patients with refractory hyperlipidemia undergoing myocardial revascularization.
About the Authors
R. N. Adzhiev
Institute of Clinical Cardiology named after A.L. Myasnikov, Russian Cardiology Research and Production Complex, Ministry of Health of Russia, Moscow
Russian Federation
Russian Federation
M. S. Safarova
Institute of Clinical Cardiology named after A.L. Myasnikov, Russian Cardiology Research and Production Complex, Ministry of Health of Russia, Moscow
Russian Federation
Russian Federation
M. V. Yezhov
Institute of Clinical Cardiology named after A.L. Myasnikov, Russian Cardiology Research and Production Complex, Ministry of Health of Russia, Moscow
Russian Federation
Russian Federation
Y. G. Matchin
Institute of Clinical Cardiology named after A.L. Myasnikov, Russian Cardiology Research and Production Complex, Ministry of Health of Russia, Moscow
Russian Federation
Russian Federation
References
1. Bramlage P., Pittrow D., Wittchen H.U. et al. Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled // Am. J. Hypertens. 2004. №17(10). P. 904–10.
2. Assman G., Schulte H. The Prospective Cardiovascular Munster Study (PROCAM): prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary artery disease // Am. Heart J. 1989. №1116. P. 1713–1724.
3. Кулаков В.И., Сметник В.П. Руководство по климактерию. М.: МИА, 2001. 685 c.
4. Скибицкий В.В., Медведева Ю.Н., Шухардина Е.Л., Скибицкая С.В. Факторы риска и структура кардиоваскулярной патологии у женщин в климаксе различного генеза // Проблемы женского здоровья. 2007. №2(3). С. 21–8.
5. Диагностика и лечение артериальной гипертензии. Российские рекомендации (третий пересмотр) // Кардиоваскулярная терапия и профилактика. 2008. №7(6). Приложение 2.
6. Poirier P., Giles T.D., Bray G.A. et al. American Heart Association; Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism // Circulation. 2006. №113. P. 898–918.
7. Aneja A., El-Atat F., McFarlane S.I., Sowers J.R. Hypertension and obesity // Recent. Progr. Horm. Res. 2004. №59. P. 169–205.
8. Rosano G.M., Vitale C., Tulli A. Managing cardiovascular risk in menopausal women // Climacteric. 2006. №9 (Suppl.1). P. 19–27.
9. Ganau A., Devereux R.B., Pickering T.G. et al. Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension // Circulation. 1990. №81. P. 25–36.
10. Alexander J.K. Obesity and the circulation // Mod. Concepts. Cardiovasc. Dis. 1963. №32. P. 799–803.
11. De Simone G., Devereux R.B. Hemorheologic abnormalities in obesity: hemodynamic and prognostic implications // Nutr. Metab. Cardiovasc. Dis. 1992. №2. P. 185–190.
Review
For citations:
Adzhiev RN, Safarova MS, Yezhov MV, Matchin YG. Aggressive lipid-lowering therapy before and after revascularization in patients with stable coronary artery disease. Meditsinskiy sovet = Medical Council. 2013;(4-2):55-61. (In Russ.) https://doi.org/10.21518/2079-701X-2013-4-2-55-61
Views:
527
Email this article 